IMR Press / FBL / Volume 19 / Issue 1 / DOI: 10.2741/4195

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Membranes to achieve immunoprotection of transplanted islets
Show Less
1 Therapeutic Micro and Nanotechnology Laboratory, Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF), 1700 4th Street, Box 2520, San Francisco, CA, 94158, USA
Front. Biosci. (Landmark Ed) 2014, 19(1), 49–76;
Published: 1 January 2014

Transplantation of islet or beta cells is seen as the cure for type 1 diabetes since it allows physiological regulation of blood glucose levels without requiring any compliance from the patients. In order to circumvent the use of immunosuppressive drugs (and their side effects), semipermeable membranes have been developed to encapsulate and immunoprotect transplanted cells. This review presents the historical developments of immunoisolation and provides an update on the current research in this field. A particular emphasis is laid on the fabrication, characterization and performance of membranes developed for immunoisolation applications.

Cell Immunoisolation
Cell Transplantation
Inorganic Membranes
Organic Membranes
Type 1 Diabetes
Back to top